Clinicopathologic Features of Adult-onset Still's Disease Complicated by Severe Liver Injury

Adult-onset Still's disease (AOSD) is a systemic inflammatory disorder. Severe liver injury has rarely been reported, although liver enzyme elevation is a common complication of AOSD. We herein report four cases of relapsed AOSD with severe liver disorder by tapering or terminating corticostero...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Internal Medicine 2024/02/15, Vol.63(4), pp.503-511
Hauptverfasser: Kurokawa, Miho, Hioki, Tomonobu, Aoyagi, Tomomi, Takahashi, Motoi, Imoto, Koji, Goya, Takeshi, Tanaka, Masatake, Kohjima, Motoyuki, Ogawa, Yoshihiro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 511
container_issue 4
container_start_page 503
container_title Internal Medicine
container_volume 63
creator Kurokawa, Miho
Hioki, Tomonobu
Aoyagi, Tomomi
Takahashi, Motoi
Imoto, Koji
Goya, Takeshi
Tanaka, Masatake
Kohjima, Motoyuki
Ogawa, Yoshihiro
description Adult-onset Still's disease (AOSD) is a systemic inflammatory disorder. Severe liver injury has rarely been reported, although liver enzyme elevation is a common complication of AOSD. We herein report four cases of relapsed AOSD with severe liver disorder by tapering or terminating corticosteroids. Liver specimens revealed robust infiltration of inflammatory cells throughout the lobule, especially cluster of differentiation (CD) 8-positive cells. Relapsed AOSD was refractory to corticosteroid reintroduction and required immunosuppressants. Severe liver injury with AOSD is pathologically characterized by extensive lobular infiltration of CD8-positive cells, and we should consider additive immunosuppressive agents on corticosteroids for treatment.
doi_str_mv 10.2169/internalmedicine.2043-23
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10937138</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2828752425</sourcerecordid><originalsourceid>FETCH-LOGICAL-c588t-20f50900beea178b2e773a1abf34e75c2c6a9ee498f1ad0604056b05cff51dce3</originalsourceid><addsrcrecordid>eNplkU9vEzEQxVcIRNPCV0CWOMBli_-s1_YJVYGWShEcCjcky-vMJo4cO9jeSvn2OEqIoFxmDvObN_Z7TYMIvqakVx9cKJCC8VtYOusCXFPcsZayZ82MsE61gjL-vJlhRWRLa7loLnPeYMykUPRlc8EE67qO8lnzc-5dcDbuTFlHH1fOolswZUqQURzRzXLypY0hQ0EPxXn_LqNPLoPJgOZxu_POmgJLNOzRAzxCArRwtaH7sJnS_lXzYjQ-w-tTv2p-3H7-Pv_SLr7d3c9vFq3lUpaW4pFjhfEAYIiQAwUhmCFmGFkHgltqe6MAOiVHYpa4xx3m_YC5HUdOlhbYVfPxqLubhmqJhVCS8XqX3NakvY7G6X8nwa31Kj5qghUThMmq8P6kkOKvCXLRW5cteG8CxClrKqkUnFbLKvr2CbqJ0yGMSikuqskK95WSR8qmmHOC8fwagvUhQ_00Q33IUFNWV9_8_Zvz4p_QKvD1CGxyMSs4AyYVZz38r9wz3R3K6cIZtGuTNAT2G1zju_U</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2957003906</pqid></control><display><type>article</type><title>Clinicopathologic Features of Adult-onset Still's Disease Complicated by Severe Liver Injury</title><source>J-STAGE Free</source><source>MEDLINE</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Kurokawa, Miho ; Hioki, Tomonobu ; Aoyagi, Tomomi ; Takahashi, Motoi ; Imoto, Koji ; Goya, Takeshi ; Tanaka, Masatake ; Kohjima, Motoyuki ; Ogawa, Yoshihiro</creator><creatorcontrib>Kurokawa, Miho ; Hioki, Tomonobu ; Aoyagi, Tomomi ; Takahashi, Motoi ; Imoto, Koji ; Goya, Takeshi ; Tanaka, Masatake ; Kohjima, Motoyuki ; Ogawa, Yoshihiro</creatorcontrib><description>Adult-onset Still's disease (AOSD) is a systemic inflammatory disorder. Severe liver injury has rarely been reported, although liver enzyme elevation is a common complication of AOSD. We herein report four cases of relapsed AOSD with severe liver disorder by tapering or terminating corticosteroids. Liver specimens revealed robust infiltration of inflammatory cells throughout the lobule, especially cluster of differentiation (CD) 8-positive cells. Relapsed AOSD was refractory to corticosteroid reintroduction and required immunosuppressants. Severe liver injury with AOSD is pathologically characterized by extensive lobular infiltration of CD8-positive cells, and we should consider additive immunosuppressive agents on corticosteroids for treatment.</description><identifier>ISSN: 0918-2918</identifier><identifier>EISSN: 1349-7235</identifier><identifier>DOI: 10.2169/internalmedicine.2043-23</identifier><identifier>PMID: 37344425</identifier><language>eng</language><publisher>Japan: The Japanese Society of Internal Medicine</publisher><subject>acute liver injury ; Adrenal Cortex Hormones - therapeutic use ; Adult ; adult-onset Still's disease ; Case Report ; CD8 antigen ; CD8-positive cells ; Cell differentiation ; Corticosteroids ; Humans ; Immunosuppressive agents ; Immunosuppressive Agents - therapeutic use ; Infiltration ; Inflammatory diseases ; Juvenile rheumatoid arthritis ; Liver ; Liver diseases ; Still's Disease, Adult-Onset - complications ; Still's Disease, Adult-Onset - drug therapy</subject><ispartof>Internal Medicine, 2024/02/15, Vol.63(4), pp.503-511</ispartof><rights>2024 by The Japanese Society of Internal Medicine</rights><rights>2024. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2024 by The Japanese Society of Internal Medicine</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c588t-20f50900beea178b2e773a1abf34e75c2c6a9ee498f1ad0604056b05cff51dce3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10937138/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10937138/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,1877,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37344425$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kurokawa, Miho</creatorcontrib><creatorcontrib>Hioki, Tomonobu</creatorcontrib><creatorcontrib>Aoyagi, Tomomi</creatorcontrib><creatorcontrib>Takahashi, Motoi</creatorcontrib><creatorcontrib>Imoto, Koji</creatorcontrib><creatorcontrib>Goya, Takeshi</creatorcontrib><creatorcontrib>Tanaka, Masatake</creatorcontrib><creatorcontrib>Kohjima, Motoyuki</creatorcontrib><creatorcontrib>Ogawa, Yoshihiro</creatorcontrib><title>Clinicopathologic Features of Adult-onset Still's Disease Complicated by Severe Liver Injury</title><title>Internal Medicine</title><addtitle>Intern. Med.</addtitle><description>Adult-onset Still's disease (AOSD) is a systemic inflammatory disorder. Severe liver injury has rarely been reported, although liver enzyme elevation is a common complication of AOSD. We herein report four cases of relapsed AOSD with severe liver disorder by tapering or terminating corticosteroids. Liver specimens revealed robust infiltration of inflammatory cells throughout the lobule, especially cluster of differentiation (CD) 8-positive cells. Relapsed AOSD was refractory to corticosteroid reintroduction and required immunosuppressants. Severe liver injury with AOSD is pathologically characterized by extensive lobular infiltration of CD8-positive cells, and we should consider additive immunosuppressive agents on corticosteroids for treatment.</description><subject>acute liver injury</subject><subject>Adrenal Cortex Hormones - therapeutic use</subject><subject>Adult</subject><subject>adult-onset Still's disease</subject><subject>Case Report</subject><subject>CD8 antigen</subject><subject>CD8-positive cells</subject><subject>Cell differentiation</subject><subject>Corticosteroids</subject><subject>Humans</subject><subject>Immunosuppressive agents</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Infiltration</subject><subject>Inflammatory diseases</subject><subject>Juvenile rheumatoid arthritis</subject><subject>Liver</subject><subject>Liver diseases</subject><subject>Still's Disease, Adult-Onset - complications</subject><subject>Still's Disease, Adult-Onset - drug therapy</subject><issn>0918-2918</issn><issn>1349-7235</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNplkU9vEzEQxVcIRNPCV0CWOMBli_-s1_YJVYGWShEcCjcky-vMJo4cO9jeSvn2OEqIoFxmDvObN_Z7TYMIvqakVx9cKJCC8VtYOusCXFPcsZayZ82MsE61gjL-vJlhRWRLa7loLnPeYMykUPRlc8EE67qO8lnzc-5dcDbuTFlHH1fOolswZUqQURzRzXLypY0hQ0EPxXn_LqNPLoPJgOZxu_POmgJLNOzRAzxCArRwtaH7sJnS_lXzYjQ-w-tTv2p-3H7-Pv_SLr7d3c9vFq3lUpaW4pFjhfEAYIiQAwUhmCFmGFkHgltqe6MAOiVHYpa4xx3m_YC5HUdOlhbYVfPxqLubhmqJhVCS8XqX3NakvY7G6X8nwa31Kj5qghUThMmq8P6kkOKvCXLRW5cteG8CxClrKqkUnFbLKvr2CbqJ0yGMSikuqskK95WSR8qmmHOC8fwagvUhQ_00Q33IUFNWV9_8_Zvz4p_QKvD1CGxyMSs4AyYVZz38r9wz3R3K6cIZtGuTNAT2G1zju_U</recordid><startdate>20240215</startdate><enddate>20240215</enddate><creator>Kurokawa, Miho</creator><creator>Hioki, Tomonobu</creator><creator>Aoyagi, Tomomi</creator><creator>Takahashi, Motoi</creator><creator>Imoto, Koji</creator><creator>Goya, Takeshi</creator><creator>Tanaka, Masatake</creator><creator>Kohjima, Motoyuki</creator><creator>Ogawa, Yoshihiro</creator><general>The Japanese Society of Internal Medicine</general><general>Japan Science and Technology Agency</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20240215</creationdate><title>Clinicopathologic Features of Adult-onset Still's Disease Complicated by Severe Liver Injury</title><author>Kurokawa, Miho ; Hioki, Tomonobu ; Aoyagi, Tomomi ; Takahashi, Motoi ; Imoto, Koji ; Goya, Takeshi ; Tanaka, Masatake ; Kohjima, Motoyuki ; Ogawa, Yoshihiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c588t-20f50900beea178b2e773a1abf34e75c2c6a9ee498f1ad0604056b05cff51dce3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>acute liver injury</topic><topic>Adrenal Cortex Hormones - therapeutic use</topic><topic>Adult</topic><topic>adult-onset Still's disease</topic><topic>Case Report</topic><topic>CD8 antigen</topic><topic>CD8-positive cells</topic><topic>Cell differentiation</topic><topic>Corticosteroids</topic><topic>Humans</topic><topic>Immunosuppressive agents</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Infiltration</topic><topic>Inflammatory diseases</topic><topic>Juvenile rheumatoid arthritis</topic><topic>Liver</topic><topic>Liver diseases</topic><topic>Still's Disease, Adult-Onset - complications</topic><topic>Still's Disease, Adult-Onset - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kurokawa, Miho</creatorcontrib><creatorcontrib>Hioki, Tomonobu</creatorcontrib><creatorcontrib>Aoyagi, Tomomi</creatorcontrib><creatorcontrib>Takahashi, Motoi</creatorcontrib><creatorcontrib>Imoto, Koji</creatorcontrib><creatorcontrib>Goya, Takeshi</creatorcontrib><creatorcontrib>Tanaka, Masatake</creatorcontrib><creatorcontrib>Kohjima, Motoyuki</creatorcontrib><creatorcontrib>Ogawa, Yoshihiro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Internal Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kurokawa, Miho</au><au>Hioki, Tomonobu</au><au>Aoyagi, Tomomi</au><au>Takahashi, Motoi</au><au>Imoto, Koji</au><au>Goya, Takeshi</au><au>Tanaka, Masatake</au><au>Kohjima, Motoyuki</au><au>Ogawa, Yoshihiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinicopathologic Features of Adult-onset Still's Disease Complicated by Severe Liver Injury</atitle><jtitle>Internal Medicine</jtitle><addtitle>Intern. Med.</addtitle><date>2024-02-15</date><risdate>2024</risdate><volume>63</volume><issue>4</issue><spage>503</spage><epage>511</epage><pages>503-511</pages><artnum>2043-23</artnum><issn>0918-2918</issn><eissn>1349-7235</eissn><abstract>Adult-onset Still's disease (AOSD) is a systemic inflammatory disorder. Severe liver injury has rarely been reported, although liver enzyme elevation is a common complication of AOSD. We herein report four cases of relapsed AOSD with severe liver disorder by tapering or terminating corticosteroids. Liver specimens revealed robust infiltration of inflammatory cells throughout the lobule, especially cluster of differentiation (CD) 8-positive cells. Relapsed AOSD was refractory to corticosteroid reintroduction and required immunosuppressants. Severe liver injury with AOSD is pathologically characterized by extensive lobular infiltration of CD8-positive cells, and we should consider additive immunosuppressive agents on corticosteroids for treatment.</abstract><cop>Japan</cop><pub>The Japanese Society of Internal Medicine</pub><pmid>37344425</pmid><doi>10.2169/internalmedicine.2043-23</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0918-2918
ispartof Internal Medicine, 2024/02/15, Vol.63(4), pp.503-511
issn 0918-2918
1349-7235
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10937138
source J-STAGE Free; MEDLINE; PubMed Central; PubMed Central Open Access
subjects acute liver injury
Adrenal Cortex Hormones - therapeutic use
Adult
adult-onset Still's disease
Case Report
CD8 antigen
CD8-positive cells
Cell differentiation
Corticosteroids
Humans
Immunosuppressive agents
Immunosuppressive Agents - therapeutic use
Infiltration
Inflammatory diseases
Juvenile rheumatoid arthritis
Liver
Liver diseases
Still's Disease, Adult-Onset - complications
Still's Disease, Adult-Onset - drug therapy
title Clinicopathologic Features of Adult-onset Still's Disease Complicated by Severe Liver Injury
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T00%3A02%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinicopathologic%20Features%20of%20Adult-onset%20Still's%20Disease%20Complicated%20by%20Severe%20Liver%20Injury&rft.jtitle=Internal%20Medicine&rft.au=Kurokawa,%20Miho&rft.date=2024-02-15&rft.volume=63&rft.issue=4&rft.spage=503&rft.epage=511&rft.pages=503-511&rft.artnum=2043-23&rft.issn=0918-2918&rft.eissn=1349-7235&rft_id=info:doi/10.2169/internalmedicine.2043-23&rft_dat=%3Cproquest_pubme%3E2828752425%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2957003906&rft_id=info:pmid/37344425&rfr_iscdi=true